Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Minutes of meetings

Beirut
2018 2019
MoM-MHPSS TF-Beirut-Nov18
MoM-MHPSS TF-Beirut-Oct18
MoM-MHPSS TF-Beirut-Sep18
MoM-MHPSS TF-Beirut-Aug18
MoM-MHPSS TF-Beirut-July18

MoM-MHPSS TF-Beirut-Apr19
MoM-MHPSS TF-Beirut-Mar19
MoM-MHPSS TF-Beirut-Feb19
MoM-MHPSS TF-Beirut-Jan19

 
2016 2017
MoM-MHPSS TF-Beirut-26-Nov16
MoM-MHPSS TF-Beirut-25-Oct16
MoM-MHPSS TF-Beirut-24-Sep16
MoM-MHPSS TF-Beirut-23-Aug16
MoM-MHPSS TF-Beirut-22-July16
MoM-MHPSS TF-Beirut-20-Apr16
MoM-MHPSS TF-Beirut-19-Mar16
MoM-MHPSS TF-Beirut-18-Feb16
MoM-MHPSS TF-Beirut-17-Jan16
MoM-MHPSS TF-Beirut-9-May17
MoM-MHPSS TF-Beirut-31-July17
MoM-MHPSS TF-Beirut-12-Sep17
MoM-MHPSS TF-Beirut-14-Nov17

Bekaa
2018 2019
MoM-MHPSS TF-Bekaa-Nov18
MoM-MHPSS TF-Bekaa-Oct18
MoM-MHPSS TF-Bekaa-​Sep18
MoM-MHPSS TF-Bekaa-Aug18
MoM-MHPSS TF-Bekaa-July18
MoM-MHPSS TF-Bekaa-June18
MoM-MHPSS TF-Bekaa-Apr19
MoM-MHPSS TF-Bekaa-Mar19
MoM-MHPSS TF-Bekaa-Feb19
MoM-MHPSS TF-Bekaa-Jan19
 
2016 2017
MoM-MHPSS TF-Bekaa-20-Dec16
MoM-MHPSS TF-Bekaa-25-Oct16
MoM-MHPSS TF-Bekaa-27-Sep16
MoM-MHPSS TF-Bekaa-01-May16

MoM-MHPSS TF-Bekaa-28 Feb17
MoM-MHPSS TF-Bekaa-24-Jan17
 

North
2018 2019
MoM-MHPSS TF-North-Nov18
MoM-MHPSS TF-North-Oct18
MoM-MHPSS TF-North-​Sep18
MoM-MHPSS TF-North-Aug18
MoM-MHPSS TF-North-July18
MoM-MHPSS TF-North-Apr19
MoM-MHPSS TF-North-Mar19
MoM-MHPSS TF-North-Feb19
MoM-MHPSS TF-North-Jan19
 
2015 2016
MoM-MHPSS TF-North-1-Aug15
MoM-MHPSS TF-North-2-Sept15
MoM-MHPSS TF-North-3-Oct15
MoM-MHPSS TF-North-4-Nov15
MoM-MHPSS TF-North-5-Dec15
MoM-MHPSS TF-North-14-Nov16
MoM-MHPSS TF-North-13-Oct16
MoM-MHPSS TF-North-12-Aug16
MoM-MHPSS TF-North-10-June16
MoM-MHPSS TF-North-9-May16
MoM-MHPSS TF-North-8-Mar16
MoM-MHPSS TF-North-7-Feb16
MoM-MHPSS TF-North-6-Jan16

South
2018 2019
MoM-MHPSS TF-South-Nov18
MoM-MHPSS TF-South-Oct18
MoM-MHPSS TF-South-​Sep18
MoM-MHPSS TF-South-Aug18
MoM-MHPSS TF-South-July18
MoM-MHPSS TF-South-Apr19
MoM-MHPSS TF-South-Mar19
MoM-MHPSS TF-South-Feb19
MoM-MHPSS TF-South-Jan19

2015 2016
MoM-MHPSS TF-South-5-Dec15
MoM-MHPSS TF-South-4-Nov15
MoM-MHPSS TF-South-3-Oct15
MoM-MHPSS TF-South-2-Sep15
MoM-MHPSS TF-South-1-Aug15
 
MoM-MHPSS TF-South-12-Oct16
MoM-MHPSS TF-South-11-Aug16
MoM-MHPSS TF-South-10-June16
MoM-MHPSS TF-South-9-May16
MoM-MHPSS TF-South-8-March16
MoM-MHPSS TF-South-7-Feb16
MoM-MHPSS TF-South-6-Jan16
 
 
 
 
 


 
    ...
    119
    ...
ATC Name B/G Ingredients Dosage Form Price
B02BD04 REFIXIA BioTech Nonacog beta pegol (factor IX) - 500IU 500IU Injectable powder for solution+solvent 76,080,435 L.L
J07BH01 ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL LIQUID) BioTech Rotavirus bovine-human , live attenuated - Liquid 2,822,069 L.L
B02BD04 REFIXIA BioTech Nonacog beta pegol (factor IX) - 1000IU 1000IU Injectable powder for solution+solvent 143,279,414 L.L
B02BD04 REFIXIA BioTech Nonacog beta pegol (factor IX) - 2000IU 2000IU Injectable powder for solution+solvent 286,711,575 L.L
R05CB13 PULMOZYME BioTech Dornase alfa (desoxyribonuclease) - 2.5mg/2.5ml 2.5mg/2.5ml Inhalation solution L.L
J07BK01 VARICELLA VACCINE LIVE BioTech Varicella-herpes zoster virus (Oka strain), grown in human diploid cells (SV-cell line), live attenuated - Injectable suspension 3,104,276 L.L
L01FE02 VECTIBIX BioTech Panitumumab - 400mg/20ml 400mg/20ml Injectable concentrated solution L.L
B02BD08 NOVOSEVEN RT BioTech Eptacog alfa (activated) recombinant - 2mg 2mg (100KIU) Injectable powder for solution+diluent 105,957,406 L.L
L01FE02 VECTIBIX BioTech Panitumumab - 100mg/5ml 100mg/5ml Injectable concentrated solution L.L
B02BD08 ARYOSEVEN RT BioTech Eptacog alfa - 1mg 1mg Injectable powder for solution+diluent 16,902,713 L.L
B02BX04 NPLATE BioTech Romiplostim - 250mcg 250mcg Injectable powder for solution L.L
B02BD08 NOVOSEVEN RT BioTech Eptacog alfa (activated) recombinant - 1mg 1mg (50KIU) Injectable powder for solution+diluent 57,890,287 L.L
L01FD02 PERJETA 420MG BioTech Pertuzumab - 420mg/14ml 420mg/14ml Injectable concentrate for solution L.L
B02BD08 NOVOSEVEN RT BioTech Eptacog alfa (activated) recombinant - 5mg 5mg (250KIU) Injectable powder for solution+diluent 264,894,762 L.L
B02BD08 RECOFACT VII BioTech Eptacog alfa (activated) recombinant - 1.2mg 1.2mg Injectable powder for solution+diluent 47,533,131 L.L
J07CA09 HEXAXIM BioTech Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg Injectable suspension 4,462,901 L.L
L01FD03 KADCYLA BioTech Trastuzumab emtansine - 100mg 100mg Injectable powder for concentrate for solution L.L
L01FD03 KADCYLA BioTech Trastuzumab emtansine - 160mg 160mg Injectable powder for concentrate for solution L.L
B02BX04 NPLATE BioTech Romiplostim - 250mcg 250mcg Injectable powder for solution 67,369,332 L.L
L01FX04 YERVOY BioTech Ipilimumab - 50mg/10ml 50mg/10ml Injectable solution L.L
L01FX05 ADCETRIS BioTech Brentuximab Vedotin - 50mg 50mg Injectable powder for concentrate for solution L.L
L01FA03 GAZYVA BioTech Obinutuzumab - 1000mg/40ml 1000mg/40ml Injectable concentrate for solution L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 60mg/0.4ml 60mg/0.4ml Injectable solution 441,042,377 L.L
L04AA33 ENTYVIO BioTech Vedolizumab - 300mg 300mg Injectable powder for concentrate for solution 152,492,033 L.L
L01FF02 KEYTRUDA BioTech Pembrolizumab - 100mg/4ml 100mg/4ml Injectable solution L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 30mg/ml 30mg/ml Injectable solution 224,585,721 L.L
L04AA33 ENTYVIO BioTech Vedolizumab - 108mg 108mg Injectable solution 88,955,869 L.L
A16AB07 MYOZYME BioTech Alglucosidase alfa, recombinant human acid - 50mg 50mg Injectable powder for concentrate for solution L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 150mg/ml 150mg/ml Injectable solution 716,437,779 L.L
L04AA33 ENTYVIO BioTech Vedolizumab - 108mg 108mg Injectable solution 88,955,869 L.L
    ...
    119
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025